Novel platform combines pathology and transcriptomics for a multi-scale analysis and visualization of the breast tumor heterogeneity

Abstract: Cancer heterogeneity is associated with drug resistance, risk of disease recurrence and metastasis. Pathology allows for the assessment of heterogeneity in the tumor. However, this assessment is limited to an overall assessment of the tumor microenvironment (TME), through measurement…